Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Study period:
Not reported
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Used in EU risk assessment for zinc sulphate, Study well documented, meets generally accepted scientific principles, acceptable for assessment.Read-across justification: Read-across from the most critical and bioavailable constituents (zinc and its compounds):The target substance is a solid inorganic UVCB substance and insoluble in water. Therefore, the transformation/dissolution study (OECD guidance 29) was conducted for the target substance to focus on the most critical bioavailable constituents of the substance. Based on the mineralogical composition, two major constituents of this target substance in addition to lead are zinc and sulphur. Zinc appears in sulphide form in the target substance. According to the 7-day and 28-day transformation/dissolution study at 100, 10 and 1 mg loadings (OECD guidance 29) zinc and sulphur are also soluble from the target substance. Since sulphur can appear either in sulphide or sulphate form in water, the read-across data focuses on the properties of zinc sulphate and other bioavailable forms of zinc. The read-across on zinc and its compounds are used in the chemical safety assessment for those endpoints where the adverse effects of the target substance can be affected by zinc content of the substance. The read-across data was justified in order to avoid unnecessary animal testing.
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
publication
Title:
No information
Author:
Litton bionetics
Year:
1974
Bibliographic source:
EU risk assessment report for zinc sulphate, 2004

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
(No data about doses, controls, observation frequency, fasting period before study, age at study initiation, housing of animals)
Principles of method if other than guideline:
Not applicable
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Zinc sulphate
EC Number:
231-793-3
EC Name:
Zinc sulphate
Cas Number:
7733-02-0
Molecular formula:
H2O4S.Zn
IUPAC Name:
zinc sulfate
Details on test material:
- Name of test material: Zinc sulphate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male
Details on test animals or test system and environmental conditions:
for more information refer to reference

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: suspended in 0.85% saline
Details on oral exposure:
animals were observed for 10 daysDOSAGE PREPARATION: Solutions were administered at pH between 6.0 and 7.0. Sodium bicarbonate was used to adjust the pH when necessary.CLASS METHOD (if applicable)- Rationale for the selection of the starting dose: A preliminary screening with small groups of 3 animals was carried out The LD50 values were then calculated according to the Litchfield and Wilcoxon method.
Doses:
50 , 100, 500, 1000 and 3000 mg/kg
No. of animals per sex per dose:
5 animals per dose
Control animals:
not specified
Details on study design:
see reference
Statistics:
No data

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
920 mg/kg bw
Mortality:
no information
Clinical signs:
other: see reference
Gross pathology:
reddened stomach and intestinal mucosa
Other findings:
No data

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated informationCriteria used for interpretation of results: EU
Conclusions:
LD50 is 920 mg/kg bw
Executive summary:

In an acute oral study zinc sulphate (type not specified, only “Zinc sulphate, Rayon”) was suspended in 0.85% saline and administered to male Sprague Dawley rats by intubation. Dose levels were 50, 100, 500, 1000 and 3000 mg/kg (5 animals per dose). Animals were observed for ten days. Toxicity signs were reddened stomach and intestinal mucosa. The LD50value was determined as 920 mg/kg bw zinc sulphate.